Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal brush-border alpha-glucosidases are a group of essential digestive enzymes, primarily sucrase-isomaltase (SI) and maltase-glucoamylase (MGAM), located on the luminal surface of the small intestinal enterocytes. These enzymes catalyze the final step of carbohydrate digestion by hydrolyzing oligosaccharides and disaccharides into absorbable monosaccharides like glucose and fructose (UniProt: P14410, O43451). By breaking down alpha-1,4 and alpha-1,6 glycosidic linkages, they play a critical role in determining the rate of glucose entry into the systemic circulation. In the context of metabolic disease, these enzymes are primary therapeutic targets for managing type 2 diabetes. Alpha-glucosidase inhibitors (AGIs) like acarbose and miglitol competitively bind to these enzymes, delaying carbohydrate absorption and effectively flattening postprandial glucose spikes (PubMed: 15181025). While highly effective for glycemic control, their use is often limited by gastrointestinal side effects resulting from the fermentation of undigested carbohydrates by colonic bacteria (NIH: NBK493214).
Competitive inhibition of intestinal alpha-glucosidase enzymes (sucrase, maltase, and glucoamylase) in the brush border of the small intestine, which delays the hydrolysis of complex carbohydrates and slows the absorption of glucose, thereby reducing postprandial blood glucose excursions (StatPearls, 2023; PubMed: 10628632).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal brush-border alpha-glucosidase (Alpha-glucosidase).